RESEARCHER PROFILE
John Demby Sandi
← Back to University of Sierra Leone
J
University of Sierra Leone
John Demby Sandi works in Viral Infections and Outbreaks Research, Viral Infections and Vectors, Virology and Viral Diseases, Biosensors and Analytical Detection, SARS-CoV-2 and COVID-19 Research. Recorded institutional associations include University of Sierra Leone, Njala University, Ministry of Health and Sanitation.
36Publications
1,049Citations
18H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time
2020 · 180 citationsThe evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
2022 · 178 citationsPredicting the evolution of the Lassa virus endemic area and population at risk over the next decades
2022 · 88 citationsAnalysis of CD8 + T cell response during the 2013–2016 Ebola epidemic in West Africa
2018 · 65 citationsEbola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: Reverse Transcription-Polymerase Chain Reaction and Cataract Surgery Outcomes of Ebola Survivors in Sierra Leone
2018 · 59 citationsField validation of recombinant antigen immunoassays for diagnosis of Lassa fever
2018 · 57 citationsSurvivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
2019 · 43 citationsHigh crossreactivity of human T cell responses between Lassa virus lineages
2020 · 38 citationsField evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
2020 · 38 citationsCross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans
2021 · 38 citationsAn Outbreak of Ebola Virus Disease in the Lassa Fever Zone
2016 · 35 citationsAntibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
2020 · 29 citationsIdentification of Common CD8+T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone
2020 · 27 citationsEndotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
2020 · 27 citationsLassa Fever among Children in Eastern Province, Sierra Leone: A 7-year Retrospective Analysis (2012–2018)
2020 · 27 citationsA prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol
2023 · 26 citationsEbola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae
2020 · 23 citationsThe evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
2022 · 21 citationsThe Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response
2021 · 13 citationsGenome-wide association study identifies human genetic variants associated with fatal outcome from Lassa fever
2024 · 10 citationsGenomic epidemiology of the 2025 mpox epidemic in Sierra Leone
2026 · 7 citationsUpper Airway Epithelial Tissue Transcriptome Analysis Reveals Immune Signatures Associated with COVID‐19 Severity in Ghanaians
2024 · 6 citationsNovel Tools for Lassa Virus Surveillance in Peri-domestic Rodents
2023 · 5 citationsRapid development and field evaluation of a portable CRISPR-based assay for Mpox during the 2025 Sierra Leone outbreak
2026 · 3 citationsEbola Virus–Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean Cohort
2024 · 2 citations
